Status:
COMPLETED
Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation
Lead Sponsor:
Meir Medical Center
Conditions:
Patella-Dislocation
Eligibility:
All Genders
18-40 years
Phase:
PHASE2
PHASE3
Brief Summary
To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.
Detailed Description
Autologous platelet-rich matrices may aid in the healing of ligaments \& tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth fac...
Eligibility Criteria
Inclusion
- age 18-40 years old
- first time patella dislocation
Exclusion
- pregnancy
- mental or physical disabilities
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00743873
Start Date
January 1 2008
End Date
March 1 2009
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir medical center
Kfar Saba, Israel